Benchmark

OncoTraj Benchmark

What is OncoTraj?

OncoTraj is a public benchmark for predicting acquired resistance to first-line osimertinib in EGFR-mutant non-small-cell lung cancer. It provides a harmonized…

Released
2026-06-09
Evaluates
Biology & Drug Discovery, Language & Knowledge, cs.LG
Openness
unknown
Importer
Claire Radar
Review status
unreviewed
Reported scores
0

Source provenance

OncoTraj paper, code and dataset

No reported scores are on record for this benchmark yet.

Which sources cite OncoTraj?

Related Biology & Drug Discovery, Language & Knowledge, cs.LG benchmarks